BA-101 / Beyond Air - LARVOL DELTA

Targeting Temozolomide-Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor. (PubMed, Cancer Med) - "Collectively, our findings strongly suggest that BA-101 has potential for further preclinical and translational development as an anticancer agent and a novel TMZ chemosensitizer for GBM therapy."

Journal • Brain Cancer • Glioblastoma • Oncology • Solid Tumor • ANXA5

NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults (GlobeNewswire)

Orphan drug • Glioblastoma